Warning: The NCBI web site requires JavaScript to function. more...
Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, Tanzania.
Kamat VR, Nyato DJ.
Malar J. 2010 Feb 26;9:61.
Related citations
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.
Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S.
Malar J. 2007 Nov 11;6:146.
Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, Sharma YD.
Malar J. 2009 May 19;8:107.
Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania.
Kabanywanyi AM, Lengeler C, Kasim P, King'eng'ena S, Schlienger R, Mulure N, Genton B.
Malar J. 2010 Feb 11;9:48.
Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C.
Malar J. 2010 Jun 15;9:164.
Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test.
Elmardi KA, Malik EM, Abdelgadir T, Ali SH, Elsyed AH, Mudather MA, Elhassan AH, Adam I.
Malar J. 2009 Mar 9;8:39.
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ.
Malar J. 2008 Jul 11;7:127.
Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions -- a user perspective.
Alba S, Dillip A, Hetzel MW, Mayumana I, Mshana C, Makemba A, Alexander M, Obrist B, Schulze A, Kessy F, Mshinda H, Lengeler C.
Malar J. 2010 Jun 15;9:163.
A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D'Alessandro U.
Trans R Soc Trop Med Hyg. 2007 Apr;101(4):344-50. Epub 2006 Sep 26.
How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
Nsimba SE.
J Ethnobiol Ethnomed. 2006 Jan 10;2:5.
Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community.
Eriksen J, Nsimba SE, Minzi OM, Sanga AJ, Petzold M, Gustafsson LL, Warsame MY, Tomson G.
Trop Med Int Health. 2005 Oct;10(10):1038-46.
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.
Malar J. 2009 Jun 8;8:125.
A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
Juma EA, Obonyo CO, Akhwale WS, Ogutu BR.
Malar J. 2008 Dec 22;7:262.
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O.
Malar J. 2007 Jun 14;6:80.
Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
Elamin SB, Awad AI, Eltayeb IB, Elmardi KA, Hassan AH, Mohamed AO, Malik EM, Mohamad TA.
Eur J Clin Pharmacol. 2010 Mar;66(3):231-7.
A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
McGready R, Tan SO, Ashley EA, Pimanpanarak M, Viladpai-Nguen J, Phaiphun L, Wüstefeld K, Barends M, Laochan N, Keereecharoen L, Lindegardh N, Singhasivanon P, White NJ, Nosten F.
PLoS Med. 2008 Dec 23;5(12):e253.
Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania.
Simba DO, Kakoko D, Tomson G, Premji Z, Petzold M, Mahindi M, Gustafsson LL.
Trans R Soc Trop Med Hyg. 2012 Jan;106(1):3-9. Epub 2011 Nov 17.
Efficacy and safety of artemehter-lumefantrine in uncomplicated falciparum malaria in Liberia.
Rasheed A, Khan SM, Awan MY, Khurshid U, Ahmad K.
J Pak Med Assoc. 2011 Feb;61(2):131-4.
Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children.
Adjei GO, Goka BQ, Binka F, Kurtzhals JA.
Expert Rev Anti Infect Ther. 2009 Aug;7(6):669-81. Review.
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Hutagalung R, Paiphun L, Ashley EA, McGready R, Brockman A, Thwai KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH.
Malar J. 2005 Sep 22;4:46.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on